Cargando…

Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications

Previous research has demonstrated aberrations in the levels of inflammatory cytokines in patients with schizophrenia (SCZ), but most of the respective studies have tested a narrow set of inflammatory cytokines. Here, we aimed to analyze broad immune profiles in the peripheral blood of the first-epi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lei, Zheng, Wen-Hui, Du, Yang, Li, Xue-Song, Yu, Yun, Wang, Hua, Cheng, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652082/
https://www.ncbi.nlm.nih.gov/pubmed/34901070
http://dx.doi.org/10.3389/fmed.2021.757655
_version_ 1784611516292530176
author Chen, Lei
Zheng, Wen-Hui
Du, Yang
Li, Xue-Song
Yu, Yun
Wang, Hua
Cheng, Yong
author_facet Chen, Lei
Zheng, Wen-Hui
Du, Yang
Li, Xue-Song
Yu, Yun
Wang, Hua
Cheng, Yong
author_sort Chen, Lei
collection PubMed
description Previous research has demonstrated aberrations in the levels of inflammatory cytokines in patients with schizophrenia (SCZ), but most of the respective studies have tested a narrow set of inflammatory cytokines. Here, we aimed to analyze broad immune profiles in the peripheral blood of the first-episode drug-free (FEDF) patients with SCZ at baseline and after an 8-week treatment with atypical antipsychotics. Serum samples from 24 FEDF patients with SCZ and 25 healthy control (HC) subjects were tested using Luminex multiplex analysis for 30 cytokines, chemokines, and growth factors. Multiple comparison tests demonstrated that interleukin-2 (IL-2), IL-4, interferon-gamma (IFN-γ), monokine induced by IFN-γ, and granulocyte colony-stimulating factor (G-CSF) levels were significantly increased, whereas those of the epidermal growth factor were significantly decreased in the FEDF patients with SCZ. Moreover, the levels of the 6 dysregulated cytokines as well as those of 12 additional soluble factors in FEDF patients with SCZ were significantly decreased after 8 weeks of antipsychotic treatment. Furthermore, the transcription of G-CSF and IFN-γ was significantly increased in FEDF patients with SCZ when compared with controls, and G-CSF and IFN-γ mRNA levels were highly correlated with their respective protein concentrations. Receiver operating characteristic curves showed that G-CSF and IFN-γ had good performance in differentiating between FEDF patients with SCZ and HC subjects. Taken together, our data revealed that FEDF patients with SCZ were accompanied by a unique pattern of immune profile, and antipsychotic medications seemed to suppress the immune function in these patients, which could be used to develop novel targets for the diagnosis and treatment of SCZ.
format Online
Article
Text
id pubmed-8652082
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86520822021-12-09 Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications Chen, Lei Zheng, Wen-Hui Du, Yang Li, Xue-Song Yu, Yun Wang, Hua Cheng, Yong Front Med (Lausanne) Medicine Previous research has demonstrated aberrations in the levels of inflammatory cytokines in patients with schizophrenia (SCZ), but most of the respective studies have tested a narrow set of inflammatory cytokines. Here, we aimed to analyze broad immune profiles in the peripheral blood of the first-episode drug-free (FEDF) patients with SCZ at baseline and after an 8-week treatment with atypical antipsychotics. Serum samples from 24 FEDF patients with SCZ and 25 healthy control (HC) subjects were tested using Luminex multiplex analysis for 30 cytokines, chemokines, and growth factors. Multiple comparison tests demonstrated that interleukin-2 (IL-2), IL-4, interferon-gamma (IFN-γ), monokine induced by IFN-γ, and granulocyte colony-stimulating factor (G-CSF) levels were significantly increased, whereas those of the epidermal growth factor were significantly decreased in the FEDF patients with SCZ. Moreover, the levels of the 6 dysregulated cytokines as well as those of 12 additional soluble factors in FEDF patients with SCZ were significantly decreased after 8 weeks of antipsychotic treatment. Furthermore, the transcription of G-CSF and IFN-γ was significantly increased in FEDF patients with SCZ when compared with controls, and G-CSF and IFN-γ mRNA levels were highly correlated with their respective protein concentrations. Receiver operating characteristic curves showed that G-CSF and IFN-γ had good performance in differentiating between FEDF patients with SCZ and HC subjects. Taken together, our data revealed that FEDF patients with SCZ were accompanied by a unique pattern of immune profile, and antipsychotic medications seemed to suppress the immune function in these patients, which could be used to develop novel targets for the diagnosis and treatment of SCZ. Frontiers Media S.A. 2021-11-24 /pmc/articles/PMC8652082/ /pubmed/34901070 http://dx.doi.org/10.3389/fmed.2021.757655 Text en Copyright © 2021 Chen, Zheng, Du, Li, Yu, Wang and Cheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Chen, Lei
Zheng, Wen-Hui
Du, Yang
Li, Xue-Song
Yu, Yun
Wang, Hua
Cheng, Yong
Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
title Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
title_full Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
title_fullStr Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
title_full_unstemmed Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
title_short Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
title_sort altered peripheral immune profiles in first-episode, drug-free patients with schizophrenia: response to antipsychotic medications
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652082/
https://www.ncbi.nlm.nih.gov/pubmed/34901070
http://dx.doi.org/10.3389/fmed.2021.757655
work_keys_str_mv AT chenlei alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
AT zhengwenhui alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
AT duyang alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
AT lixuesong alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
AT yuyun alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
AT wanghua alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
AT chengyong alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications